Radiofrequency (RF) ablation is a minimally invasive medical technique which blisters the affected tissue, leaving only a scar, which disappears over time. RF ablation technology is used for pain management in and around the affected tissue initiating agonizing chronic pain. This procedure is used after all other methods of pain management have proven useless. As a result of the high technical efficacy and minimal invasive nature, the global RF ablation devices market is anticipated to observe a remarkable growth over the forthcoming years. The global RF ablation devices market is estimated to reach US$ 8.85 billion by 2020.
Growing occurrence of target disorders associated with pain like BPO (benign prostatic obstruction), osteoporosis pain, and the growing global aged population pool is projected to assist this market as high effect rendering drivers. Technological invention in each product segment as regards to price efficacy and consumer affability is also likely to enhance market demand.
The market growth is backed by the upsurge in occurrence of cardiovascular diseases like atrial fibrillation, prevalence of patients suffering from cancer and pain, and growing call for minimally invasive procedures. Nevertheless, the market is restricted by the high cost, inadequate awareness about the technique, and disposal of other cures. It is, however, expected that the pros of the market are higher than cons. Furthermore, profitable growth prospects are opening out in emerging economies, untouched market in the developing zones, and scientific developments in RFA.
Surgical oncology ruled the global market in terms of share and was valued at over US$ 1 billion in 2013 primarily owing to high procedure numbers and cancer occurrence. Nonetheless, the RF ablation devices for hypertension market because of collective demand from patients and ensuing increase in R&D ingenuities is anticipated to grow at the fastest CAGR in the coming years.
RF ablation devices find usage in oncology, cardiology, cosmetology, pain management, gynecology, and hypertension, thus motivating their demand. The intensifying incidence of arthritis is one of the crucial drivers of the global RF ablation devices market for pain management. Additionally to this, makers are continuously investing in R&D to cultivate technologically advanced products, which in turn is firing the growth of the market. The competences of the devices are significantly refining due to progressions in technology and this will upsurge their acceptance rates.
Uneasiness, tissue scorching, bruising, hot pain, and puffiness are some of the side effects linked with RF ablation devices. These side effects generate trepidations amongst patients and hamper their adoption. Nevertheless, the influence of this restraint is estimated to diminish over the years as technical developments in this field help shrink these side effects. Another factor dissuading the implementation of RF ablation devices for pain management is its non-applicability for a large pool suffering from back pain. On the other hand, developing economies in Asia Pacific and Latin America are anticipated to hold profitable openings for growth in the upcoming years.
Read more on healthcare on: